Currently, NLM is not updating the Disaster Information Management Research Center (DIMRC) website, and is limiting updates to the Disaster Lit database to COVID-19 related data collection tools found in the DR2.
We are no longer adding links to other new disaster-related information. The content of select resources from Disaster Lit will be digitized and made available through Digital Collections and Bookshelf.
Annotation:This web page for laboratories provides information about how the CDC is using SARS-CoV-2 in various ways, including: To test serum collected from people who have recovered from COVID-19 to look for antibody that might block viral infections; and to determine when people shed live virus during the disease. This information has shaped CDC’s guidance on when to discontinue transmission-based precautions for patients....[See more] [See less]
Annotation:
This one-hour, two-minute presentation discusses what higher education leaders, staff, and faculty should do to help young people of color successfully navigate today’s campus climate, social distancing protocols, and remote learning experiences.
Annotation:This web page, updated on October 25, 2020, provides information about the CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay, which is a real-time reverse-transcriptase polymerase chain reaction (RT-PCR) test that detects and differentiates RNA from SARS-CoV-2, influenza A virus, and influenza B virus in upper or lower respiratory specimens. The Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for this test on July 2, 2020....[See more] [See less]
Annotation:The COVID-19 pandemic has presented challenges in healthcare for those who may be at greater risk for adverse health outcomes such as people who use drugs or people who have a substance use disorder. To better facilitate provision of care, the CDC organized this one-hour Clinician Outreach and Communication Activities (COCA) call to highlight existing resources and exceptions for clinicians who prescribe medications for opioid use disorder, increase awareness of existing community-based linkage to care resources, and discuss the outpatient telemedicine experience from a front-line provider perspective....[See more] [See less]
Annotation:
This web page, updated on October 21, 2020, provides training resources in these topic areas: Background on COVID-19; COVID-19 disease-specific information; Prevent spread of COVID-19; and Training catalog.
Annotation:This 57-minute webinar discusses effective leadership strategies that will allow for successful management of COVID-19 on inpatient psychiatric units, how to develop policies and procedures that will lead to efficient identification and isolation of cases, and how to identify necessary modifications to unit programming that must be made to prevent the spread of infection....[See more] [See less]
Annotation:The ASPR At-Risk Individuals Program led this three-part webinar series on implementing telehealth services to address the access and functional needs of at-risk individuals, in partnership with the Department of Housing and Urban Development, during COVID-19 pandemic....[See more] [See less]
Annotation:
This one-hour, six-minute event explores mental health factors employers should consider, along with solutions and strategies for promoting mental health in today’s landscape, and creating a supportive workplace for young people of color.
Annotation:This 54-minute webinar describes the epidemiology of acute COVID-19, including post-infectious manifestations and the unique aspects of caring for children during a pandemic. It also discusses the features of multi-system inflammatory syndrome in children (MIS-C) and how to devise a diagnostic and acute management plan and integrate potential post-recovery complications into the development of follow-up plans for a child with MIS-C....[See more] [See less]
Annotation:With a new infectious disease threat at hand, scientists at the NIH swiftly developed a vaccine candidate against the novel coronavirus that causes COVID-19. The pre-clinical effort for a fast, reliable, and universal vaccine was driven in part by the speaker in this one-hour presentation....[See more] [See less]